IRIS
LARUSSA, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 772
EU - Europa 372
AS - Asia 104
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
Totale 1.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 736
IT - Italia 151
GB - Regno Unito 87
SE - Svezia 53
IR - Iran 38
CA - Canada 33
IN - India 32
NL - Olanda 22
DE - Germania 17
CN - Cina 10
TW - Taiwan 9
AU - Australia 8
FR - Francia 6
RO - Romania 6
TR - Turchia 6
EU - Europa 4
PL - Polonia 4
UA - Ucraina 4
BR - Brasile 3
CL - Cile 3
ES - Italia 3
MX - Messico 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
HU - Ungheria 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SG - Singapore 1
Totale 1.273
Salva come PNG Salva come JPEG
Città #
Chandler 152
Chicago 86
London 82
Lawrence 68
Princeton 68
Wilmington 41
Ashburn 32
Ottawa 30
Catanzaro 28
Des Moines 21
Redwood City 19
Mumbai 17
Mendicino 12
Praia A Mare 9
Collegeville 7
Pune 7
Rome 7
Tehran 7
Cittanova 6
Redmond 6
Hanover 5
Norwalk 5
Clearwater 4
Horia 4
Milan 4
Selargius 4
Taipei 4
Bade District 3
Benevento 3
Bratislava 3
Kahramanmaraş 3
Miguel Hidalgo 3
Nanjing 3
Paris 3
Phoenix 3
Rende 3
Zabki 3
Ann Arbor 2
Bari 2
Beijing 2
Bungarribee 2
Cape Town 2
Capurso 2
Castel Campagnano 2
Chelsea 2
Esslingen am Neckar 2
Frankfurt am Main 2
Fremont 2
Leuven 2
Lyon 2
Miami 2
Pasargad 2
Pécs 2
Riyadh 2
Silea 2
São Paulo 2
Toronto 2
Vienna 2
Wanchai 2
Acireale 1
Adelaide 1
Agnone 1
Antalya 1
Auckland 1
Boardman 1
Bologna 1
Bucharest 1
Burlington 1
Böblingen 1
Cairo 1
Cardiff 1
Castrovillari 1
Ciudad del Este 1
Dearborn 1
Delhi 1
Dipignano 1
Domanico 1
Dubai 1
Falkenstein 1
Florence 1
Guangzhou 1
Jaipur 1
Jerusalem 1
Kermanshah 1
Kundan 1
Lanciano 1
Leawood 1
Lecce 1
Los Angeles 1
Lubbock 1
Madrid 1
Markham 1
Melbourne 1
Montepaone 1
Montesilvano 1
Mountain View 1
New Taipei 1
Nijmegen 1
Penrith 1
Raniye 1
Totale 850
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 56
Dietary polyphenolsand non-alcoholic fatty liver disease 54
The role of gluten-free diet in nonalcoholic fatty liver disease development 45
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 42
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 42
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 37
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 35
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 35
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 33
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 30
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 29
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 29
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 29
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 28
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 26
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 26
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 25
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 24
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 23
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 23
Bone mineralization in celiac disease 23
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 22
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 22
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 21
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 21
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 20
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 20
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 19
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 19
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 19
Gut microbiota and non-alcoholic fatty liver disease 19
Crohn disease: Identification, diagnosis, and clinical management. 18
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 17
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 17
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 17
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 17
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 17
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 17
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 17
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 16
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 16
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 16
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 15
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 15
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 15
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 13
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 13
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 12
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 12
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 11
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 11
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 10
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 10
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 9
Liver Cirrhosis Complications Management At The Emergency Department 9
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 9
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 9
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 8
Liver steatosis in celiac disease: the open door 8
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 8
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 8
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 8
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 8
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 7
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 7
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 7
Potential role of nutraceutical compounds in inflammatory bowel disease 7
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 7
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 7
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 7
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 7
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 6
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 6
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 5
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 5
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 4
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 1
Totale 1.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 6 12 3 5 11 3 46 31
2020/2021135 9 8 2 16 17 13 10 19 32 7 2 0
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024265 69 20 25 16 10 75 6 15 27 2 0 0
Totale 1.385